Eli Lilly & Co is a general drug manufacturer company located in Indiana, United States, which is part of the Healthcare sector, and is traded under the ticker LLY on the NYSE exchange.
Eli Lilly & Co stock last closed at $819.36, up 0.9% from the previous day, and has decreased 7.24% in one year. It has overperformed other stocks in the Drug Manufacturers - General industry by 0 percentage points. Eli Lilly & Co stock is currently +21.01% from its 52-week low of $677.09, and -15.75% from its 52-week high of $972.53.
At the moment, there are 947.74M shares of LLY outstanding. The market cap of LLY is $776.54B. In the past 24 hours, 2.76M LLY shares were traded.
You will need a brokerage account in order to access the NYSE market and buy LLY stock.
In our opinion, eToro is the best place to buy stocks. eToro gives you:
Get $10 towards your stock purchase by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've selected the right brokerage, you need to fill out some personal info so you can invest in LLY today.
Now that you've filled out your info on the best app for stock investing, you need to deposit funds:
Check out the video below for more details transferring money into your new investment account.
After you have identified the best place to buy Eli Lilly & Co stock, it's important to research their stock before you invest, so you can wrap your head around the risk and opportunity.
WallStreetZen was created to help part-time investors do more in-depth fundamental analysis.
You can see all of the due diligence checks on LLY's stock page.
Analysts use many financial metrics, analyses, models, and charts to gauge LLY's true value.
Using relative valuations ratios:
You can do additional valuation analysis on LLY's stock here.
Out of 9 Equities analysts who give recommendations on LLY, the consensus analyst rating on LLY is a Strong Buy
It's important to note that analyst forecasts are not stock recommendations, nor are they financial advice.
Asad Haider, a bottom 47% analyst from Goldman Sachs upgrades LLY to a strong buy rating and lowers their LLY price target from $892.00 to $888.00, on Apr 8, 2025.
Goldman Sachs's Asad Haider upgraded their rating on Eli Lilly & Co (NYSE: LLY) from Hold to Strong Buy on 2025/04/08. The analyst also lowered their price target by 0.4% from $892 to $888.
Initiating coverage on the name, Haider attributed their upgrade to the stock's valuation offering a "compelling entry point into the sector's premier topline grower" after the recent selloff.
The analyst predicted that Eli Lilly & Co. "will maintain its pole position" as the leader in the anti-obesity medication market, which Goldman Sachs expects to triple in size from $28B to $95B by 2030.
Mohit Bansal, a top 16% analyst from Wells Fargo maintains LLY with a strong buy rating and raises their LLY price target from $970.00 to $1,100.00, on Mar 5, 2025.
Srikripa Devarakonda, a bottom 7% analyst from Truist Securities maintains LLY with a strong buy rating and raises their LLY price target from $1,029.00 to $1,038.00, on Feb 3, 2025.
Peter Verdult, a bottom 23% analyst from Citigroup maintains LLY with a strong buy rating and lowers their LLY price target from $1,250.00 to $1,190.00, on Jan 28, 2025.
You can dive deeper into what analysts are forecasting on the Eli Lilly & Co stock forecast page.
Last year, LLY earnings were $11.11B. Over the past five year, LLY's earnings have grown by 15.25% per year. This was faster than the Drug Manufacturers - General industry average of 7.53%.
Last year, LLY revenue was $49.00B. During the past five year, LLY's revenue has gone up by 16.24% per year. This was faster than the Drug Manufacturers - General industry average of 9.71%.
Dig into LLY's earnings and revenue performance here.
In the last 12 months, executives and large shareholders at LLY have sold more shares than they have bought.
Donald A. Zakrowski, SVP Finance CAO of LLY, was the latest LLY insider to sell. They sold $716,410.00 worth of LLY stock on May 27, 2025.
Research more about who owns LLY stock here.
Eli Lilly & Co pays a dividend of 0.5%, compared to the Drug Manufacturers - General industry's average dividend yield of 3.41%. If you owned $1,000 of LLY stock, you would have been paid $5.00 in the past 12 months.
Eli Lilly & Co dividend payments have consistently grown over the past decade and have remained stable.
Dig into more data about Eli Lilly & Co dividend yield and history here.
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other investors have to say.
You have two main types of orders:
Press the Open Trade button and eToro will execute your order.
If you want additional help investing in stocks on eToro, watch the how to video below:
Now that you own some LLY shares, you'll want to keep up with your company.
Create a watchlist to see the latest developments about your LLY stock.
To reiterate, here are the 6 steps you need to take to buy Eli Lilly & Co stock right now:
If you are looking for a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to get updates on your investment in Eli Lilly & Co, add LLY to your watchlist by clicking the button below.